Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for symptom burden in NSCLC chemoradiation
NCT01636934Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2012
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in non-small cell lung cancer (NSCLC), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2012; status: completed.
02
Drugs
minocycline
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01636934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01636934.